Wilson Mark Andrew Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
23
Insider Sells Sum
$614,844.11

Insider Activity of Wilson Mark Andrew

According to the SEC Form 4 filings, Wilson Mark Andrew, being in a position of

  1. Chief Legal Officer at Nektar Therapeutics,
    оver the last 12 months, has bought 0 shares, and sold 630 shares for $34,196,
    over all time since 2020-05-18, has bought 0 shares, and sold 169627 shares for $673,713.

Biography of Wilson Mark Andrew

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $34,1961100

Comparison of Insiders on Amount of Buys and Sells

2025-11-25SaleNektar Therapeutics
NKTR
Chief Legal Officer
630
0.0031%
$54.28$34,196+11.65%
2025-08-19SaleNektar Therapeutics
NKTR
Chief Legal Officer
676
0.0035%
$26.59$17,975+131.21%
2025-05-19SaleNektar Therapeutics
NKTR
Chief Legal Officer
9,996
0.0052%
$0.67$6,697+478.7%
2025-02-19SaleNektar Therapeutics
NKTR
Chief Legal Officer
11,040
0.0057%
$1.01$11,150+82.87%
2024-12-24SaleNektar Therapeutics
NKTR
Chief Legal Officer
16,560
0.0088%
$0.89$14,738+64.9%
2024-12-23SaleNektar Therapeutics
NKTR
Chief Legal Officer
33,402
0.018%
$0.90$30,062+64.77%
2024-11-19SaleNektar Therapeutics
NKTR
Chief Legal Officer
6,407
0.0034%
$1.01$6,471-1.94%
2024-08-19SaleNektar Therapeutics
NKTR
Chief Legal Officer
5,651
0.003%
$1.28$7,233-24.06%
2024-05-17SaleNektar Therapeutics
NKTR
Chief Legal Officer
6,260
0.0033%
$1.75$10,955-36.36%
2024-02-20SaleNektar Therapeutics
NKTR
Chief Legal Officer
7,606
0.0041%
$0.68$5,172+82.41%
2023-11-17SaleNektar Therapeutics
NKTR
Chief Legal Officer
7,179
0.0038%
$0.49$3,518+153.13%
2023-08-16SaleNektar Therapeutics
NKTR
Chief Legal Officer
7,221
0.0039%
$0.78$5,632-7.79%
2023-05-16SaleNektar Therapeutics
NKTR
Chief Legal Officer
7,543
0.004%
$0.72$5,431-18.24%
2023-02-16SaleNektar Therapeutics
NKTR
Chief Legal Officer
8,275
0.0045%
$3.00$24,825-80.29%
2022-11-16SaleNektar Therapeutics
NKTR
Chief Legal Officer
8,690
0.0047%
$3.57$31,023-79.26%
2022-08-15SaleNektar Therapeutics
NKTR
SVP & General Counsel
3,189
0.0016%
$4.76$15,180-53.97%
2022-05-16SaleNektar Therapeutics
NKTR
SVP & General Counsel
3,136
0.0017%
$3.95$12,387-17.01%
2022-02-16SaleNektar Therapeutics
NKTR
SVP & General Counsel
3,661
0.0019%
$10.95$40,088-66.85%
2021-11-16SaleNektar Therapeutics
NKTR
SVP & General Counsel
6,564
0.0035%
$13.16$86,382-66.33%
2021-08-16SaleNektar Therapeutics
NKTR
SVP & General Counsel
1,910
0.001%
$13.83$26,415-22.59%
Total: 26
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.